Immunoregulation and Clinical Implications of ANGPT2/TIE2+ M-MDSC Signature in Non-Small Cell Lung Cancer.
Saved in:
| Title: | Immunoregulation and Clinical Implications of ANGPT2/TIE2+ M-MDSC Signature in Non-Small Cell Lung Cancer. |
|---|---|
| Authors: | Lauret Marie Joseph E; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France., Laheurte C; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France.; Etablissement Français du Sang Bourgogne Franche-Comté, Plateforme de Biomonitoring, Besançon, France.; INSERM CIC-1431, CHU Besançon, Besançon, France., Jary M; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France.; Service d'Oncologie médicale, CHU Besançon, Besançon, France., Boullerot L; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France.; INSERM CIC-1431, CHU Besançon, Besançon, France., Asgarov K; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France., Gravelin E; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France.; INSERM CIC-1431, CHU Besançon, Besançon, France., Bouard A; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France., Rangan L; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France., Dosset M; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France., Borg C; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France.; INSERM CIC-1431, CHU Besançon, Besançon, France.; Service d'Oncologie médicale, CHU Besançon, Besançon, France., Adotévi O; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France. olivier.adotevi@univ-fcomte.fr.; Etablissement Français du Sang Bourgogne Franche-Comté, Plateforme de Biomonitoring, Besançon, France.; INSERM CIC-1431, CHU Besançon, Besançon, France.; Service d'Oncologie médicale, CHU Besançon, Besançon, France. |
| Source: | Cancer immunology research [Cancer Immunol Res] 2020 Feb; Vol. 8 (2), pp. 268-279. Date of Electronic Publication: 2019 Dec 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31871121 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunoregulation and Clinical Implications of ANGPT2/TIE2<superscript>+</superscript> M-MDSC Signature in Non-Small Cell Lung Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lauret+Marie+Joseph+E%22">Lauret Marie Joseph E</searchLink>; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Laheurte+C%22">Laheurte C</searchLink>; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France.; Etablissement Français du Sang Bourgogne Franche-Comté, Plateforme de Biomonitoring, Besançon, France.; INSERM CIC-1431, CHU Besançon, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Jary+M%22">Jary M</searchLink>; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France.; Service d'Oncologie médicale, CHU Besançon, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Boullerot+L%22">Boullerot L</searchLink>; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France.; INSERM CIC-1431, CHU Besançon, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Asgarov+K%22">Asgarov K</searchLink>; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Gravelin+E%22">Gravelin E</searchLink>; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France.; INSERM CIC-1431, CHU Besançon, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Bouard+A%22">Bouard A</searchLink>; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Rangan+L%22">Rangan L</searchLink>; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Dosset+M%22">Dosset M</searchLink>; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Borg+C%22">Borg C</searchLink>; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France.; INSERM CIC-1431, CHU Besançon, Besançon, France.; Service d'Oncologie médicale, CHU Besançon, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Adotévi+O%22">Adotévi O</searchLink>; Université Bourgogne Franche-Comté, INSERM, EFS, BFC, UMR1098, RIGHT, Besançon, France. olivier.adotevi@univ-fcomte.fr.; Etablissement Français du Sang Bourgogne Franche-Comté, Plateforme de Biomonitoring, Besançon, France.; INSERM CIC-1431, CHU Besançon, Besançon, France.; Service d'Oncologie médicale, CHU Besançon, Besançon, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101614637%22">Cancer immunology research</searchLink> [Cancer Immunol Res] 2020 Feb; Vol. 8 (2), pp. 268-279. <i>Date of Electronic Publication: </i>2019 Dec 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101614637 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2326-6074 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223266066%22">23266066 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31871121 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/2326-6066.CIR-19-0326 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 268 Titles: – TitleFull: Immunoregulation and Clinical Implications of ANGPT2/TIE2+ M-MDSC Signature in Non-Small Cell Lung Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lauret Marie Joseph E – PersonEntity: Name: NameFull: Laheurte C – PersonEntity: Name: NameFull: Jary M – PersonEntity: Name: NameFull: Boullerot L – PersonEntity: Name: NameFull: Asgarov K – PersonEntity: Name: NameFull: Gravelin E – PersonEntity: Name: NameFull: Bouard A – PersonEntity: Name: NameFull: Rangan L – PersonEntity: Name: NameFull: Dosset M – PersonEntity: Name: NameFull: Borg C – PersonEntity: Name: NameFull: Adotévi O IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2020 Feb Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 2326-6074 Numbering: – Type: volume Value: 8 – Type: issue Value: 2 Titles: – TitleFull: Cancer immunology research Type: main |
| ResultId | 1 |